ERGO.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (10 Nov 2023 @ 11:29):

Stats
Today's Volume	33 234.00
Average Volume	922 955
Market Cap	771.71M
EPS	£0 ( 2024-03-18 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	48.14
ATR14	£15.31 (1.14%)

Volume Correlation

Long: 0.36 (neutral)

Short: 0.07 (neutral)

Signal:(66.053) Neutral

Ergomed PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Ergomed PLC Correlation - Currency/Commodity

-0.89
( strong negative )

-0.85
( strong negative )

0.76
( moderate )

-0.19
( neutral )

0.31
( neutral )

0.80
( moderate )

Ergomed PLC Financials

Annual	2022
Revenue:	£145.26M
Gross Profit:	£59.15M (40.72 %)
EPS:	£0.300

Q2	2018
Revenue:	£0.00
Gross Profit:	£0.00 (0.00 %)
EPS:	£0

Q2	2017
Revenue:	£0.00
Gross Profit:	£0.00 (0.00 %)
EPS:	£0

Q2	2016
Revenue:	£0.00
Gross Profit:	£0.00 (0.00 %)
EPS:	£0

Financial Reports:

No articles found.

Ergomed PLC

Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance services for pharmaceutical, biotechnology, and generics companies. It focuses on various therapeutic areas, including oncology, haematology, allergy, respiratory, and neurology/CNS, as well as develops orphan drugs. The company also provides site support services. The company was formerly known as Ergomed Clinical Research Limited and changed its name to Ergomed plc in June 2014. Ergomed plc was founded in 1997 and is headquartered in Guildford, the United Kingdom.